Introduction:
Process intensification in the biopharma industry has gained popularity in recent years, with a focus on continuous manufacturing and scaling-out. However, the implementation of process intensification strategies can be complex and expensive. Companies need to ensure they choose the right approach to prevent over-investment in terms of time, money, and labor. Strategic process intensification based on data analysis and optimization can help companies make informed decisions.
- Process intensification in biopharma is a complex and costly undertaking.
- Choosing the right approach and strategy is crucial to prevent over-investment.
- Strategic process intensification should be based on data analysis and optimization.
- The stepwise approach, focusing on each step of the process and optimizing connections between systems, is recommended.
Conclusion:
Process intensification in the biopharma industry requires careful consideration and planning to prevent over-investment. Companies should base their approach on data analysis and optimization, using a stepwise method to optimize each step of the process and improve connections between systems. By following these strategies, companies can effectively implement process intensification and achieve the desired improvements in time savings, facility footprint reduction, and increased productivity.
